Literature DB >> 17402842

Candida urinary tract infections: treatment options.

Anurag N Malani1, Carol A Kauffman.   

Abstract

Candiduria is a nonspecific finding that occurs with contamination of a urine sample, colonization of an indwelling catheter and/or the bladder, symptomatic cystitis and invasive upper tract infection. Most patients are colonized and do not require antifungal therapy. Removing predisposing factors, such as indwelling catheters and antibiotics, will clear candiduria in almost 50% of asymptomatic patients. For patients with symptomatic Candida urinary tract infections, a variety of treatment options are available. Fluconazole is the antifungal agent of choice, achieving high urine concentrations with the oral formulation. Rarely, amphotericin B or flucytosine are used. Newer azole agents and echinocandins are not recommended for the treatment of urinary tract infections since they fail to achieve adequate urine concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17402842     DOI: 10.1586/14787210.5.2.277

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  10 in total

1.  Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.

Authors:  L Toner; N Papa; S H Aliyu; H Dev; N Lawrentschuk; Samih Al-Hayek
Journal:  QJM       Date:  2015-11-04

2.  Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.

Authors:  Hallie S Rane; Stella M Bernardo; Amy B Howell; Samuel A Lee
Journal:  J Antimicrob Chemother       Date:  2013-10-10       Impact factor: 5.790

3.  Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration.

Authors:  Elisabete Ricardo; Fréderic Grenouillet; Isabel M Miranda; Raquel M Silva; Guilluame Eglin; Nadège Devillard; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 4.  [Candida infections in the elderly].

Authors:  H Hof; G Mikus
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

5.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

6.  Ureteric obstruction due to fungus-ball in a chronically immunosuppressed patient.

Authors:  Niall F Davis; Lisa G Smyth; Elizabeth Mulcahy; Tim Scanlon; Liam Casserly; Hugh D Flood
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

7.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 8.  Mycoses in the elderly.

Authors:  H Hof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

9.  Urinary tract infections in women: etiology and treatment options.

Authors:  Daniele Minardi; Gianluca d'Anzeo; Daniele Cantoro; Alessandro Conti; Giovanni Muzzonigro
Journal:  Int J Gen Med       Date:  2011-04-19

10.  Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey.

Authors:  Márió Gajdács; Ilona Dóczi; Marianna Ábrók; Andrea Lázár; Katalin Burián
Journal:  Cent European J Urol       Date:  2019-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.